Trial Profile
Efficacy of indacaterol in patients with acute exacerbation of chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 10 Dec 2015 New trial record